Hairclone is a brand that offers hair follicle banking services for individuals looking to preserve their hair for future use. The process involves surgically extracting around 120 hair follicles at one of HairClone's partner clinics. These follicles are then cryopreserved at extremely low temperatures, ensuring that the cells remain in a state of suspended animation and do not age.

The banked follicles remain the property of the patient and can be requested at any time for HairClone's cell therapy or other potential treatments. By banking follicles early on, individuals can retain high cell activity and potentially benefit from HairClone's personalized cell therapy once it receives regulatory approval. HairClone's revolutionary treatment aims to rebuild hair follicles by replacing lost dermal papilla cells.

They plan to begin clinical work in the UK in 2024 and eventually offer treatments worldwide. The cost of treatment is expected to be competitive with hair transplants. HairClone's research is focused on using human tissue and advanced omics techniques, eliminating the need for animal testing